Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Farrow Jeffrey S

SEC-identified person · CIK 1405253 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Tarsus Pharmaceuticals, Inc. TARS See Remarks filed 2023 - 2026
Sonus Pharmaceuticals INC ogxi Director filed 2026 - 2026
Global Blood Therapeutics, Inc. GBT Chief Financial Officer filed 2016 - 2022
ZS Pharma, Inc. ZSPH Chief Financial Officer filed 2015 - 2015
Hyperion Therapeutics INC HPTX CFO & Secretary filed 2012 - 2015
Renovis INC RNVS V.P., Finance and CAO filed 2007 - 2008

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.